aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Vyant Bio, Inc. is a biotechnology drug discovery company focused on developing and commercializing proprietary genomic tests and services to enhance cancer treatment. The firm also provides preclinical oncology and immuno-oncology services, serving customers globally. Based in Rutherford, United States, Vyant Bio aims to revolutionize cancer care through innovative genomic solutions.
Vyant Bio has made significant strides in the biotech industry, contributing to advancements in personalized cancer treatment. The company's genomic tests and preclinical services have been instrumental in aiding research and development for more effective cancer therapies.
Operating Status
Active
Ownership Type(s)
Public
Main Product(s)
Cancer Treatment, Genomic Tests
Technology
Biotech
Tags
Healthtech
Model Types
Data Information, Software
Revenue Type(s)
Transactional, Recurring
Customer Type(s)
Enterprise, Healthcare
Geographic Exposure
United States
When was Vyant Bio founded?
Vyant Bio was founded in 1999.
Where is Vyant Bio’s headquarters located?
Vyant Bio’s headquarters is located in Cherry Hill, US.
How many employees does Vyant Bio have?
Vyant Bio has 50 employees as of Feb 6, 2024.
Add Comparison
Total Employees Over Time
50
As of Feb 2024
Vyant Bio Address
Cherry Hill,
08002
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts